منابع مشابه
There Are No Bad Anticancer Agents , Only Bad Clinical Trial
Unfortunately, the vast majority (90%) of new anticancer agents designed in the laboratory never make it into routine clinical use. The hypothesis of this lecture is that many new agents fail in the clinic because the appropriate clinical trial(s) that could exploit the attributes of the new agent are not performed. An appreciation that both bench and clinical investigations are difficult endea...
متن کاملGenetic polymorphisms in diabetics and non-diabetics.
Phenotype distributions of some genetic polymorphisms are reported in a sample of 721 diabetics and 515 non-diabetic, non-blood donor controls. Reference is also made, in the case of the ABO and Rhesus systems, to previously published results for blood donors resident in the Durham area. Non-insulin-taking diabetics show an increased frequency of blood group A1 (and A1 + A2) when compared with ...
متن کاملEffect of emulin on blood glucose in type 2 diabetics.
Emulin™ is a patented blend of chlorogenic acid, myricetin, and quercetin that has shown efficacy in reducing midday and post-oral glucose tolerance test (OGTT) area under the curve (AUC) glucose in streptozotocin-treated rats. The purpose of this study was to determine if similar effects would be evident in type 2 diabetic humans. Forty human subjects with confirmed type 2 diabetes (10 each in...
متن کاملEffect of Yoga on Glycemic Profile in Diabetics
Background: Yoga is a holistic health system that forms a part of Ayurvedic medicine. Yoga is described as physical and mental technique that can be effectively used to create physical and mental well-being. Since its introduction into modern culture, yoga has enjoyed a tremendous growth in popularity as an adjunct to healthy living. The purpose of yoga is to achieve highest level of integratio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Cancer
سال: 2012
ISSN: 1474-175X,1474-1768
DOI: 10.1038/nrc3295